138 related articles for article (PubMed ID: 26399285)
1. HIV-TB co-infection in children: associated factors and access to HIV services in Lagos, Nigeria.
Daniel OJ; Adejumo OA; Gidado M; Abdur-Razzaq HA; Jaiyesimi EO
Public Health Action; 2015 Sep; 5(3):165-9. PubMed ID: 26399285
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcomes of drug susceptible Tuberculosis in private health facilities in Lagos, South-West Nigeria.
Oladimeji O; Adepoju V; Anyiam FE; San JE; Odugbemi BA; Hyera FLM; Sibiya MN; Yaya S; Zoakah AI; Lawson L
PLoS One; 2021; 16(1):e0244581. PubMed ID: 33471851
[TBL] [Abstract][Full Text] [Related]
3. Magnitude and treatment outcomes of pulmonary tuberculosis patients in a poor urban slum of Abia State, Nigeria.
Ogbudebe CL; Izuogu S; Abu CE
Int J Mycobacteriol; 2016 Jun; 5(2):205-10. PubMed ID: 27242233
[TBL] [Abstract][Full Text] [Related]
4. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
Tshitenge S; Ogunbanjo GA; Citeya A
Afr J Prim Health Care Fam Med; 2018 Nov; 10(1):e1-e5. PubMed ID: 30456967
[TBL] [Abstract][Full Text] [Related]
5. Public-private mix for TB and TB-HIV care in Lagos, Nigeria.
Daniel OJ; Adedeji Adejumo O; Abdur-Razzaq HA; Ngozi Adejumo E; Salako AA
Int J Tuberc Lung Dis; 2013 Sep; 17(9):1195-8. PubMed ID: 23928168
[TBL] [Abstract][Full Text] [Related]
6. Assessing the accessibility of HIV care packages among tuberculosis patients in the Northwest Region, Cameroon.
Njozing NB; Miguel SS; Tih PM; Hurtig AK
BMC Public Health; 2010 Mar; 10():129. PubMed ID: 20226022
[TBL] [Abstract][Full Text] [Related]
7. Linking private, for-profit providers to public sector services for HIV and tuberculosis co-infected patients: A systematic review.
Hudson M; Rutherford GW; Weiser S; Fair E
PLoS One; 2018; 13(4):e0194960. PubMed ID: 29634772
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of collaboration in the TB and HIV control programme in Oromia Region, Ethiopia: Seven years of retrospective data.
Sisay S; Mekonen A; Abera A; Berhan Y; Kebede T; Ferede A
Int J Infect Dis; 2018 Dec; 77():74-81. PubMed ID: 30336266
[TBL] [Abstract][Full Text] [Related]
9. FACTORS ASSOCIATED WITH TB/HIV CO-INFECTION AMONG DRUG SENSITIVE TUBERCULOSIS PATIENTS MANAGED IN A SECONDARY HEALTH FACILITY IN LAGOS, NIGERIA.
Adejumo OA; Daniel OJ; Otesanya AF; Adegbola AA; Femi-Adebayo T; Bowale A; Adesola S; Kuku OO; Otemuyiwa KO; Oladega SN; Johnson EO; Falana AA; Dawodu O; Owuna H; Osoba G; Dacosta A
Afr J Infect Dis; 2017; 11(2):75-82. PubMed ID: 28670643
[TBL] [Abstract][Full Text] [Related]
10. Integrating tuberculosis and HIV services in rural Kenya: uptake and outcomes.
Owiti P; Zachariah R; Bissell K; Kumar AM; Diero L; Carter EJ; Gardner A
Public Health Action; 2015 Mar; 5(1):36-44. PubMed ID: 26400600
[TBL] [Abstract][Full Text] [Related]
11. Clinical correlate of tuberculosis in HIV co-infected children at the University of Abuja Teaching Hospital, Gwagwalada, Nigeria.
Okechukwu AA; Okechukwu OI
Niger J Clin Pract; 2011; 14(2):206-11. PubMed ID: 21860141
[TBL] [Abstract][Full Text] [Related]
12. Five years retrospective cohort analysis of treatment outcomes of TB-HIV patients at a PEPFAR/DOTS Centre in South Eastern Nigeria.
Babatunde OI; Christiandolus EO; Bismarck EC; Emmanuel OI; Chike AC; Gabriel EI
Afr Health Sci; 2016 Sep; 16(3):655-662. PubMed ID: 27917196
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus-associated tuberculosis care in Botswana: evidence from a real-world setting.
Muyaya LM; Musanda EM; Tamuzi JL
BMC Infect Dis; 2019 Sep; 19(1):767. PubMed ID: 31477055
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with antiretroviral treatment interruption in human immunodeficiency virus (HIV)-1-infected children attending the Jos University Teaching Hospital, Jos, Nigeria.
Ebonyi AO; Ejeliogu EU; Okpe SE; Shwe DD; Yiltok ES; Ochoga MO; Oguche S
Niger Med J; 2015; 56(1):43-7. PubMed ID: 25657493
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis and HIV co-infections in Jamaican children.
Geoghagen M; Farr JA; Hambleton I; Pierre R; Christie CD
West Indian Med J; 2004 Oct; 53(5):339-45. PubMed ID: 15675501
[TBL] [Abstract][Full Text] [Related]
16. Results of rapid and successful integration of HIV diagnosis and care into tuberculosis services in Benin.
Ferroussier O; Dlodlo RA; Capo-Chichi D; Boillot F; Gninafon M; Trébucq A; Fujiwara PI
Int J Tuberc Lung Dis; 2013 Nov; 17(11):1405-10. PubMed ID: 24125442
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria.
Chang CA; Meloni ST; Eisen G; Chaplin B; Akande P; Okonkwo P; Rawizza HE; Tchetgen Tchetgen E; Kanki PJ
Open Forum Infect Dis; 2015 Dec; 2(4):ofv154. PubMed ID: 26613097
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral treatment among co-infected tuberculosis patients in integrated and non-integrated facilities.
Ledibane TD; Motlhanke SC; Rose A; Kruger WH; Ledibane NR; Claassens MM
Public Health Action; 2015 Jun; 5(2):112-5. PubMed ID: 26400380
[TBL] [Abstract][Full Text] [Related]
19. High mortality in tuberculosis patients despite HIV interventions in Swaziland.
Mchunu G; van Griensven J; Hinderaker SG; Kizito W; Sikhondze W; Manzi M; Dlamini T; Harries AD
Public Health Action; 2016 Jun; 6(2):105-10. PubMed ID: 27358803
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
